Careers  |  Sign In  |  Register  |   Twitter

Supreme Court Case to Rule on Generic Drug Case

A new article from The New York Times reports a new Supreme Court case that will determine whether a pharmaceutical company will be permitted to pay competitors to restrict the sale of generic copies of best-selling drugs. The case, Federal Trade Commission v. Watson Pharmaceuticals, “could settle a decade-long battle between federal regulators, who say the deals violate antitrust law, and the pharmaceutical industry, which contends that they are really just settlements of disputes over patents that protect the billions of dollars they pour into research and development.”

Read it in The New York Times.